Status:
COMPLETED
Randomized Controlled Trial to Compare Two Anti-scorpion Serums
Lead Sponsor:
Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.
Conditions:
Scorpion Sting
Eligibility:
All Genders
15-60 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the efficiency and safety of the treatment against sting scorpion, using two serums, one elaborated by Birmex versus other commercial serum
Detailed Description
We consider relevant conduct this study because the poisoning scorpion bite represents a public health problem. This is a randomized clinical trial, which included 120 subjects of both sexes aged 15 ...
Eligibility Criteria
Inclusion
- Sting scorpion
- Informed consent
- Age 15-60
- Either sex
- Resident in study area
Exclusion
- Previous treatment with gammaglobulin
- Blood transfusion at any stage of life
- Sensitivity or intolerance to serums antiscorpion or horse products
- Pregnancy
- Some immunodeficiency
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00739440
Start Date
August 1 2008
End Date
November 1 2008
Last Update
August 7 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.